Usefulness of dexmedetomidine for prevention of emergent agitation in infants undergoing palatoplasty

Usefulness of dexmedetomidine for prevention of emergent agitation in infants undergoing palatoplasty - Usefulness of dexmedetomidine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009869

Enrollment

Registered

2013-01-25

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cleft palate

Interventions

In the Dex group, Dex was given from about 10 minutes before the end of the operation. In the saline group, the equivalent amount of saline was administered in the same manner.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants were required to be ASA physical status class1, aged 10 to 14 months years old, weight between 7 and 10 kg, and have a height between 70 and 80 cm.

Exclusion criteria

Exclusion criteria: Exclusion criteria included patient refusal, ASA class2, cardiovascular disease, or allergy.

Design outcomes

Primary

Measure	Time frame
To determine the effects of Dex on postoperative recovery in infants undergoing palatoplasty.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026